COMBI-AD: Adjuvant dabrafenib (D) plus trametinib (T) for resected stage III BRAF V600E/K–mutant melanomaAxel Hauschild, John M. Kirkwood, Ru‐Rong Ji et al.|Annals of Oncology|2017Cited by 7